Companies / OS Therapies Inc

OS Therapies Inc

NYSE: OSTXCIK 1795091ROCKVILLE, MD

Financials

Revenue
Net income$-28.75M
Total debt$250.0K
Cash
Diluted EPS$-0.98
Shares outstanding44.5M

Ownership

44.5M shares outstanding · as of May 14, 2026
4.6%Institutions
Ownership
Institutions4.58%2,038,535
Public float95.42%42,499,571

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Acevedo Christopher P.Chief Financial Officer
Ciccio JohnDirector
Galzahr KarimFormerDirector
Petit RobertSee Remarks
Romness Paul A.CEOPresident and CEO · Director

Institutional holders 27

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 22, 2026McKean-Dieser Avril Suzette
Director
GrantStock options (right to buy)+50K
50,000
0.11% of shares
low
Jan 22, 2026Search Theodore F.
Director
GrantStock options (right to buy)+50K
50,000
0.11% of shares
low
Jan 22, 2026Ciccio John
Director
GrantStock options (right to buy)+50K
50,000
0.11% of shares
low
Jan 22, 2026Acevedo Christopher P.
Executive
GrantStock options (right to buy)+100K
100,000
0.22% of shares
low
Jan 22, 2026Petit Robert
Executive
GrantStock options (right to buy)+100K
100,000
0.22% of shares
low
Jan 22, 2026Romness Paul A.
CEO
GrantStock options (right to buy)+1.0M
1,000,000
2.25% of shares
low
Jan 22, 2026Jarry Olivier Roger
Director
GrantStock options (right to buy)+50K
50,000
0.11% of shares
low
Jan 22, 2026Galzahr Karim
Director
GrantStock options (right to buy)+50K
50,000
0.11% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OSTXCommon StockEquity68764Y207BBG00Y71N7G7